Science 37 (NASDAQ:SNCE – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Science 37 Inc. provides operating system for agile clinical trials. Science 37 Inc., formerly known as LifeSci Acquisition II Corp., is based in […]
Science 37 (NASDAQ:SNCE – Get Rating) and iSpecimen (NASDAQ:ISPC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Valuation & Earnings This table compares Science 37 and iSpecimen’s […]
Science 37 (NASDAQ:SNCE – Get Rating) and ProMIS Neurosciences (OTCMKTS:ARFXF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations […]